Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Aurora Cannabis Inc., through its subsidiaries, is engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering, and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, and home cultivation.
  • Current market environment: negative. Prices of production are 21.6% lower compared to the last 12 months (LTM)
  • Prices of production are at 20.6% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 13.4% (LTM), projected 4.9%
  • Share price is 1 326.3% higher than minimum and 41.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-0.5x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: ACB
Share price, USD:  (-3.6%)5.42
year average price 4.89  


year start price 6.08 2024-08-31

min close price 3.46 2025-02-03

max close price 6.62 2025-02-13

current price 5.42 2025-08-31
Common stocks: 141 750 746

Dividend Yield:  0.0%
FCF Yield LTM / expected: 13.4% / 4.9%
EV / LTM EBITDA: -0.5x
Production prices change from LTM: -21.6%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 768
Net Debt ($m): -124
EV (Enterprise Value): 644
EBITDA LTM ($m): -1 193
EV / LTM EBITDA: -0.5x
Price to Book: 6.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-08-29247wallst.com

Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?

2025-08-06zacks.com

ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y

2025-08-06seekingalpha.com

Aurora Cannabis Inc. (ACB) Q1 2026 Earnings Call Transcript

2025-08-06zacks.com

Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Beats Revenue Estimates

2025-06-18zacks.com

Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates

2025-03-19marijuanastocks.com

3 Canadian Marijuana Stocks To Watch For Future Gains 2025

2025-03-17zacks.com

Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?

2025-03-05marijuanastocks.com

Top Marijuana Stocks To Know In Today's Stock Market 2025

2025-02-26zacks.com

Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?

2025-02-21zacks.com

Best Momentum Stocks to Buy for February 21st
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company